News > When and which Covid-19 vaccines are likely to be available in Asia

When and which Covid-19 vaccines are likely to be available in Asia

Moderna Inc applied for US and European emergency authorisation of its Covid-19 vaccine based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns.

The head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on November 23 the positive late-state trial result of the candidate will allow it to, before securing the OK for a full rollout by February or March.